Skip to content

The effect of intrauterine instillation of E-Aminocaproeic Acid during hysteroscopic operations in the management of intractable uterine hemorrhage

The effect of intrauterine instillation of E-Aminocaproeic Acid during hysteroscopic operations in the management of intractable uterine hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105235283N2
Enrollment
144
Registered
2011-06-07
Start date
2011-03-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Submucous leiomyoma. Condition 2: endometrial tickness. Condition 3: Polyp of corpus uteri. Submucous leiomyoma of uterus Endometrial glandular hyperplasia Polyp of corpus uteri

Interventions

Intervention 1: Group A: E-Aminocaproeic Acid in dextrose 5% inside one liter of the dextrose 5%. Intervention 2: Group B: placebo i.e., dextrose 5% in the same form inside one liter of the dextrose
Placebo
Treatment - Drugs
Group B: placebo i.e., dextrose 5% in the same form inside one liter of the dextrose 5%

Sponsors

Women's Reproductive Health Research Center, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: history of persistent uterine bleeding accompanied with endometrial thickness, endometrial polyp or submucous myoma less than 3 cm in diameters and patients' willing to participate Exclusion criteria: Patients with the history of cardiopulmonary and liver disease, hypertension, diabetes, hyperlipidemia, cervical and uterine cancers, submucous myomas more than 3 cm in diameters

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Interaoperative bleeding. Timepoint: at the end of surgery. Method of measurement: Visual scale.;Duration of surgery. Timepoint: from the beginning to the end of surgery. Method of measurement: time based on minute.;Volume of injected media. Timepoint: after finishing of every one litre serum. Method of measurement: number of injected serums.;Success in completion of operation. Timepoint: from the beginning to the end of surgery. Method of measurement: based on miutes.

Secondary

MeasureTime frame
Post operative bleeding. Timepoint: every 15 minuts. Method of measurement: clinical signs and symptoms.;Blood pressure. Timepoint: continious. Method of measurement: monitor.;Bradycardia. Timepoint: continious. Method of measurement: monitor.;Gastrointestinal side effects. Timepoint: every 1 hour. Method of measurement: clinical signs and symptoms.;Headache. Timepoint: every 1 hours. Method of measurement: clinical symptoms.;Leg muscles cramp. Timepoint: every 6 hours. Method of measurement: clinical symptoms.;Duration of hospital stay. Timepoint: every 6 hours. Method of measurement: hours.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactManizheh Sayyah-Melli

Tabriz University of Medical Sciences

manizheh.sayyahmelli@gmail.com+98 41 1554 1221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026